Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 01 - 18 tags : Covid-19 save search
Sun Life introduces employer community to ThrivePass to help manage workplace vaccine verification and testing for COVID-19
Published: 2022-01-18 (Crawled : 19:00) - prnewswire.com
SLF | News 0 d | $51.05 0.77% 46K
|
Finance
|
| O: 0.88%
H: 0.0%
C: -1.77%
covid-19 covid work test vaccine
APDN Announces Continued Momentum in COVID-19 Testing Demand
Published: 2022-01-18 (Crawled : 16:00) - adnas.com
APDN | $0.3699 9.57% 24K
|
Commercial Services
|
| O: -0.25%
H: 1.99%
C: 0.5%
covid-19 ema covid test
Aditxt Submits Two Requests for Emergency Use Authorization to FDA for AditxtScore™ for COVID-19 Tests Which Measure the Quantity and Quality of Antibodies Against COVID-19 and its Variants Including Omicron
Published: 2022-01-18 (Crawled : 15:00) - biospace.com/
ADTX | $2.41 6.6K
|
Health Technology
|
| O: 2.73%
H: 1.66%
C: -6.11%
covid-19 fda covid authorization test merge antibody emergency use authorization
Brazilian Health Regulatory Agency (ANVISA) Authorizes Sorrento Phase 2 Clinical Trial of COVI-MSC in COVID-19 Patients With Persistent Pulmonary Compromise After Recovery (Long-Hauler)
Published: 2022-01-18 (Crawled : 15:00) - biospace.com/
SRNE | $0.024 57K
|
Health Technology
|
| O: 2.35%
H: 0.0%
C: 0.0%
covid-19 health phase 2 trial covid brazil
Global COVID-19 EIA/ELISA Medical Devices Market Landscape Report 2021: Comparative Analysis of the Products at Various Stages of Development
Published: 2022-01-18 (Crawled : 14:00) - prnewswire.com
OCDX | $17.63 0.45%
|
|
| O: -2.65%
H: 1.39%
C: -0.91%
IPA | $1.24 3.9K
|
Professional, Scientific, and T...
|
| O: 0.32%
H: 2.22%
C: -1.59%
ABT | News | $107.24 1.87% 2M
|
Health Technology
|
| O: -2.15%
H: 0.0%
C: 0.0%
TECH | $62.315 0.17% 190K
|
Health Technology
|
| O: -4.04%
H: 0.39%
C: -1.01%
ADMA 4 | $6.18 -0.32% 500K
|
Health Technology
|
| O: 7.34%
H: 0.0%
C: 0.0%
covid-19 ces device covid report
NRx Pharmaceuticals Announces Expansion of ZYESAMI® (aviptadil) US Expanded Access and Right to Try Programs for Patients with COVID-19 Respiratory Failure who have Exhausted All Approved Treatments
Published: 2022-01-18 (Crawled : 13:00) - biospace.com/
NRXP 1 d | $3.135 3.81% 110K
|
Manufacturing
|
| O: -0.57%
H: 0.0%
C: -8.68%
covid-19 zyesami treatment aviptadil als expansion respiratory covid
Merck and Ridgeback Announce Supply Agreement with UNICEF for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine
Published: 2022-01-18 (Crawled : 13:00) - biospace.com/
FNCTF | News | $11.0354 320
|
Communications
|
| O: -0.4%
H: 0.0%
C: -0.58%
MRK | $125.12 -0.09% 1.6M
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
covid-19 covid molnupiravir antiviral
Molecular Partners Finalizes License Agreement with Novartis for Ensovibep for COVID-19
Published: 2022-01-18 (Crawled : 07:00) - globenewswire.com
MOLN | $3.74 5.5K
|
Professional, Scientific, and T...
|
| O: -8.83%
H: 0.4%
C: -4.19%
covid-19 novartis ensovibep license covid molecular
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.0606 68.33% 250M
|
NVFY | $3.45 63.51% 20M
|
Consumer Durables
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
ZCMD | $1.86 28.28% 29M
|
Commercial Services
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
AULT | $0.3022 24.82% 51M
|
Manufacturing
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.